selenocysteine has been researched along with Carcinoma, Renal Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, W; Diamond, AM; Jacobs, D; Kajdacsy-Balla, A; Zhen, S | 1 |
| Addo, SN; Chung, N; Domanus, MH; Hu, M; Hutti, JE; Lu, C; Miller, CP; Mitra, D; Petiwala, S; Sun, N | 1 |
| Bhattacharya, A; Chintala, S; Durrani, FA; Rustum, YM | 1 |
3 other study(ies) available for selenocysteine and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Associations of selenoprotein expression and gene methylation with the outcome of clear cell renal carcinoma.
Topics: Carcinoma, Renal Cell; Humans; Intracellular Signaling Peptides and Proteins; Kidney Neoplasms; Methylation; Neoplasm Proteins; Selenocysteine; Selenoproteins | 2023 |
A Multicenter Case-Historical Control Study on Short-Term Outcomes of Tele-Intensive Care Unit.
Topics: Carcinoma, Renal Cell; Cell Line, Tumor; CRISPR-Cas Systems; DNA Damage; DNA Repair; Gene Editing; Humans; Kidney Neoplasms; Selenocysteine; Sequence Analysis, RNA; Signal Transduction; von Hippel-Lindau Disease; Von Hippel-Lindau Tumor Suppressor Protein | 2019 |
Non-Coding Micro RNAs and Hypoxia-Inducible Factors Are Selenium Targets for Development of a Mechanism-Based Combination Strategy in Clear-Cell Renal Cell Carcinoma-Bench-to-Bedside Therapy.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Renal Cell; Cell Line, Tumor; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Neoplasms; Mice, Nude; MicroRNAs; Selenocysteine; Selenomethionine; Topotecan | 2018 |